{"id":"https://openalex.org/W2790069484","doi":"https://doi.org/10.1021/acs.molpharmaceut.7b01055","title":"Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer","display_name":"Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer","alternate_titles":[],"publication_year":2018,"publication_date":"2018-03-05","ids":{"openalex":"https://openalex.org/W2790069484","doi":"https://doi.org/10.1021/acs.molpharmaceut.7b01055","mag":"2790069484","pmid":"https://pubmed.ncbi.nlm.nih.gov/29502423"},"language":"en","primary_location":{"id":"doi:10.1021/acs.molpharmaceut.7b01055","doi":"https://doi.org/10.1021/acs.molpharmaceut.7b01055","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.7b01055","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2790069484"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110546911","display_name":"Ayaka Okamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1298590031","display_name":"Shizuoka University","ror":"https://ror.org/01w6wtk13","country_code":"JP","type":"education","lineage":["https://openalex.org/I1298590031"]},{"id":"https://openalex.org/I150240954","display_name":"University of Shizuoka","ror":"https://ror.org/04rvw0k47","country_code":"JP","type":"education","lineage":["https://openalex.org/I150240954"]},{"id":"https://openalex.org/I205924995","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I1319490839","https://openalex.org/I205924995"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ayaka Okamoto","raw_affiliation_strings":["Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan","Japan Society for the Promotion of Science, 5-3-1 Kojimachi, Chiyoda-ku, Tokyo 102-0083, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan","institution_ids":["https://openalex.org/I1298590031","https://openalex.org/I150240954"]},{"raw_affiliation_string":"Japan Society for the Promotion of Science, 5-3-1 Kojimachi, Chiyoda-ku, Tokyo 102-0083, Japan","institution_ids":["https://openalex.org/I205924995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103484530","display_name":"Tomohiro Asai","orcid":"https://orcid.org/0000-0002-2388-4414","observed_orcids":["https://orcid.org/0000-0002-2388-4414"]},"institutions":[{"id":"https://openalex.org/I1298590031","display_name":"Shizuoka University","ror":"https://ror.org/01w6wtk13","country_code":"JP","type":"education","lineage":["https://openalex.org/I1298590031"]},{"id":"https://openalex.org/I150240954","display_name":"University of Shizuoka","ror":"https://ror.org/04rvw0k47","country_code":"JP","type":"education","lineage":["https://openalex.org/I150240954"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tomohiro Asai","raw_affiliation_strings":["Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan","institution_ids":["https://openalex.org/I1298590031","https://openalex.org/I150240954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005944932","display_name":"Yusuke Hirai","orcid":"https://orcid.org/0000-0003-1796-3535","observed_orcids":["https://orcid.org/0000-0003-1796-3535"]},"institutions":[{"id":"https://openalex.org/I1298590031","display_name":"Shizuoka University","ror":"https://ror.org/01w6wtk13","country_code":"JP","type":"education","lineage":["https://openalex.org/I1298590031"]},{"id":"https://openalex.org/I150240954","display_name":"University of Shizuoka","ror":"https://ror.org/04rvw0k47","country_code":"JP","type":"education","lineage":["https://openalex.org/I150240954"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yusuke Hirai","raw_affiliation_strings":["Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan","institution_ids":["https://openalex.org/I1298590031","https://openalex.org/I150240954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083297048","display_name":"Kosuke Shimizu","orcid":"https://orcid.org/0000-0003-3789-2447","observed_orcids":["https://orcid.org/0000-0003-3789-2447"]},"institutions":[{"id":"https://openalex.org/I1298590031","display_name":"Shizuoka University","ror":"https://ror.org/01w6wtk13","country_code":"JP","type":"education","lineage":["https://openalex.org/I1298590031"]},{"id":"https://openalex.org/I13491362","display_name":"Hamamatsu University","ror":"https://ror.org/057vy9683","country_code":"JP","type":"education","lineage":["https://openalex.org/I13491362"]},{"id":"https://openalex.org/I150240954","display_name":"University of Shizuoka","ror":"https://ror.org/04rvw0k47","country_code":"JP","type":"education","lineage":["https://openalex.org/I150240954"]},{"id":"https://openalex.org/I3123035732","display_name":"Hamamatsu University School of Medicine","ror":"https://ror.org/00ndx3g44","country_code":"JP","type":"education","lineage":["https://openalex.org/I3123035732"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kosuke Shimizu","raw_affiliation_strings":["Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan","Department of Molecular Imaging, Institute for Medical Photonics Research, Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka 431-3192 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan","institution_ids":["https://openalex.org/I1298590031","https://openalex.org/I150240954"]},{"raw_affiliation_string":"Department of Molecular Imaging, Institute for Medical Photonics Research, Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka 431-3192 Japan","institution_ids":["https://openalex.org/I13491362","https://openalex.org/I3123035732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076883274","display_name":"Hiroyuki Koide","orcid":"https://orcid.org/0000-0003-1763-6593","observed_orcids":["https://orcid.org/0000-0003-1763-6593"]},"institutions":[{"id":"https://openalex.org/I1298590031","display_name":"Shizuoka University","ror":"https://ror.org/01w6wtk13","country_code":"JP","type":"education","lineage":["https://openalex.org/I1298590031"]},{"id":"https://openalex.org/I150240954","display_name":"University of Shizuoka","ror":"https://ror.org/04rvw0k47","country_code":"JP","type":"education","lineage":["https://openalex.org/I150240954"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroyuki Koide","raw_affiliation_strings":["Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan","institution_ids":["https://openalex.org/I1298590031","https://openalex.org/I150240954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113939848","display_name":"Tetsuo Minamino","orcid":"https://orcid.org/0000-0002-5424-4081","observed_orcids":["https://orcid.org/0000-0002-5424-4081"]},"institutions":[{"id":"https://openalex.org/I201933988","display_name":"Kagawa University","ror":"https://ror.org/04j7mzp05","country_code":"JP","type":"education","lineage":["https://openalex.org/I201933988"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tetsuo Minamino","raw_affiliation_strings":["Department of Cardiovascular Medicine, Graduate School of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793 Japan","institution_ids":["https://openalex.org/I201933988"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023882539","display_name":"Naoto Oku","orcid":"https://orcid.org/0000-0002-1933-2545","observed_orcids":["https://orcid.org/0000-0002-1933-2545"]},"institutions":[{"id":"https://openalex.org/I1298590031","display_name":"Shizuoka University","ror":"https://ror.org/01w6wtk13","country_code":"JP","type":"education","lineage":["https://openalex.org/I1298590031"]},{"id":"https://openalex.org/I150240954","display_name":"University of Shizuoka","ror":"https://ror.org/04rvw0k47","country_code":"JP","type":"education","lineage":["https://openalex.org/I150240954"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Naoto Oku","raw_affiliation_strings":["Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan"],"raw_orcid":"https://orcid.org/0000-0002-1933-2545","affiliations":[{"raw_affiliation_string":"Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan","institution_ids":["https://openalex.org/I1298590031","https://openalex.org/I150240954"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5023882539"],"corresponding_institution_ids":["https://openalex.org/I1298590031","https://openalex.org/I150240954"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.8647,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.86619344,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"15","issue":"4","first_page":"1495","last_page":"1504"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10958","display_name":"Ultrasound and Hyperthermia Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9810000061988831},{"id":"https://openalex.org/keywords/sirna-delivery","display_name":"siRNA delivery","score":0.9150000214576721},{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.9549999833106995},{"id":"https://openalex.org/keywords/hb-egf","display_name":"HB-EGF","score":0.9539999961853027},{"id":"https://openalex.org/keywords/plk1","display_name":"PLK1","score":0.9760000109672546},{"id":"https://openalex.org/keywords/rna-interference","display_name":"RNA interference","score":0.7799999713897705},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.6549999713897705},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":0.8840000033378601},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.7310000061988831},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9359999895095825}],"concepts":[{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7055708765983582},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6323878765106201},{"id":"https://openalex.org/C25938499","wikidata":"https://www.wikidata.org/wiki/Q7663812","display_name":"Systemic administration","level":3,"score":0.5787683725357056},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.56230229139328},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.548029899597168},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5110124349594116},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4870765507221222},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38409852981567383},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3472413420677185},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3306535482406616},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.243563711643219},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2015007734298706},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000097869","descriptor_name":"Polo-Like Kinase 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007140","descriptor_name":"Immunoglobulin Fab Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007140","descriptor_name":"Immunoglobulin Fab Fragments","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D034622","descriptor_name":"RNA Interference","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D066257","descriptor_name":"Heparin-binding EGF-like Growth Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D066257","descriptor_name":"Heparin-binding EGF-like Growth Factor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D066257","descriptor_name":"Heparin-binding EGF-like Growth Factor","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.molpharmaceut.7b01055","doi":"https://doi.org/10.1021/acs.molpharmaceut.7b01055","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.7b01055","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:29502423","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29502423","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1489554123","display_name":"Development of antibody-drug conjugate to diagnose and treat vulnerable plaque","funder_award_id":"15H04821","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G2220253987","display_name":"Novel strategy of tumor treatiment via the normalization  of tumor vasculature by microRNA","funder_award_id":"26670018","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G2607071033","display_name":"\u816b\u760d\u9078\u629e\u7684\u6838\u9178\u9001\u9054\u6280\u8853\u3092\u7528\u3044\u305f\u304c\u3093\u6cbb\u7642\u6cd5\u306e\u958b\u767a","funder_award_id":"15J11660","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G8175365505","display_name":"Design of Synthetic Polymer Nanoparticles Specifically Capturing Indole for improvement of uremia symptom","funder_award_id":"17K14519","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G8479408632","display_name":"Development of functional lipid nanoparticles for RNA interference-based therapy","funder_award_id":"16K08201","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W923668049","https://openalex.org/W1647075334","https://openalex.org/W1863202510","https://openalex.org/W1867238542","https://openalex.org/W1871308790","https://openalex.org/W1964146045","https://openalex.org/W1964667070","https://openalex.org/W1974782633","https://openalex.org/W1995224853","https://openalex.org/W2009931781","https://openalex.org/W2013089475","https://openalex.org/W2015784530","https://openalex.org/W2020411912","https://openalex.org/W2023106557","https://openalex.org/W2024381057","https://openalex.org/W2031252270","https://openalex.org/W2033545273","https://openalex.org/W2036565476","https://openalex.org/W2044046734","https://openalex.org/W2046267543","https://openalex.org/W2053856024","https://openalex.org/W2053904584","https://openalex.org/W2058088002","https://openalex.org/W2070003597","https://openalex.org/W2088478532","https://openalex.org/W2097255042","https://openalex.org/W2110355766","https://openalex.org/W2138745567","https://openalex.org/W2140241614","https://openalex.org/W2166903671","https://openalex.org/W2261992653","https://openalex.org/W2463007765","https://openalex.org/W2489923882","https://openalex.org/W2557735732","https://openalex.org/W2601514701","https://openalex.org/W2738523285"],"related_works":["https://openalex.org/W1964667070","https://openalex.org/W2602730871","https://openalex.org/W2792549792","https://openalex.org/W4398216622","https://openalex.org/W3204637127","https://openalex.org/W2913419794","https://openalex.org/W4399915190","https://openalex.org/W2036565476","https://openalex.org/W2585721815","https://openalex.org/W4409729408"],"abstract_inverted_index":{"Triple-negative":[0],"breast":[1,31,76,159],"cancer":[2,77],"is":[3,147],"one":[4],"of":[5,29,87,108,120,135,154],"the":[6,34,112,152],"intractable":[7],"cancers":[8],"that":[9,94,144],"are":[10],"not":[11],"sensitive":[12],"to":[13,100],"treatment":[14,28,131,153],"with":[15,46,132],"existing":[16],"molecular-targeted":[17],"drugs.":[18],"Recently,":[19],"there":[20],"has":[21],"been":[22],"much":[23],"interest":[24],"in":[25,103,111],"RNA":[26],"interference-mediated":[27],"triple-negative":[30,75,158],"cancer.":[32,160],"In":[33,123],"present":[35],"study,":[36],"we":[37],"have":[38],"developed":[39],"lipid":[40],"nanoparticles":[41],"encapsulating":[42],"siRNA":[43,92,99,136],"(LNP-siRNA)":[44],"decorated":[45],"an":[47,138],"Fab'":[48],"antibody":[49],"against":[50],"heparin-binding":[51],"EGF-like":[52],"growth":[53,126],"factor":[54],"(\u03b1HB-EGF":[55],"LNP-siRNA).":[56],"\u03b1HB-EGF":[57,95,121,145],"LNP-siRNA":[58],"targeting":[59],"polo-like":[60],"kinase":[61],"1":[62],"(PLK1)":[63],"was":[64,114,127],"prepared":[65],"and":[66,90,137],"evaluated":[67],"for":[68,151],"its":[69],"anticancer":[70],"effect":[71],"using":[72],"MDA-MB-231":[73,104],"human":[74],"cells":[78],"overexpressing":[79],"HB-EGF":[80],"on":[81],"their":[82],"cell":[83],"surface.":[84],"Biodistribution":[85],"data":[86],"radioisotope-labeled":[88],"LNP":[89,96,146],"fluorescence-labeled":[91],"indicated":[93],"effectively":[97],"delivered":[98],"tumor":[101,125],"tissue":[102],"carcinoma-bearing":[105],"mice.":[106],"Expression":[107],"PLK1":[109],"protein":[110],"tumors":[113],"clearly":[115],"suppressed":[116],"after":[117],"intravenous":[118],"injection":[119],"LNP-siPLK1.":[122],"addition,":[124],"significantly":[128],"inhibited":[129],"by":[130],"this":[133],"formulation":[134],"antibody-modified":[139],"carrier.":[140],"These":[141],"findings":[142],"indicate":[143],"a":[148],"promising":[149],"carrier":[150],"HB-EGF-expressing":[155],"cancers,":[156],"including":[157]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2790069484","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2018-03-29T00:00:00"}
